Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy
Macrophages infiltrating tumour tissues or residing in the microenvironment of solid tumours
are known as tumour-associated macrophages (TAMs). These specialized immune cells …
are known as tumour-associated macrophages (TAMs). These specialized immune cells …
Pre-metastatic niche: formation, characteristics and therapeutic implication
Y Wang, J Jia, F Wang, Y Fang, Y Yang… - … and Targeted Therapy, 2024 - nature.com
Distant metastasis is a primary cause of mortality and contributes to poor surgical outcomes
in cancer patients. Before the development of organ-specific metastasis, the formation of a …
in cancer patients. Before the development of organ-specific metastasis, the formation of a …
Tumor-associated macrophages: An effective player of the tumor microenvironment
U Basak, T Sarkar, S Mukherjee… - Frontiers in …, 2023 - frontiersin.org
Cancer progression is primarily caused by interactions between transformed cells and the
components of the tumor microenvironment (TME). TAMs (tumor-associated macrophages) …
components of the tumor microenvironment (TME). TAMs (tumor-associated macrophages) …
Decoding the spatiotemporal heterogeneity of tumor-associated macrophages
X Chu, Y Tian, C Lv - Molecular Cancer, 2024 - Springer
Tumor-associated macrophages (TAMs) are pivotal in cancer progression, influencing tumor
growth, angiogenesis, and immune evasion. This review explores the spatial and temporal …
growth, angiogenesis, and immune evasion. This review explores the spatial and temporal …
HEARTSVG: a fast and accurate method for identifying spatially variable genes in large-scale spatial transcriptomics
X Yuan, Y Ma, R Gao, S Cui, Y Wang, B Fa… - Nature …, 2024 - nature.com
Identifying spatially variable genes (SVGs) is crucial for understanding the spatiotemporal
characteristics of diseases and tissue structures, posing a distinctive challenge in spatial …
characteristics of diseases and tissue structures, posing a distinctive challenge in spatial …
Targeting of TAMs: can we be more clever than cancer cells?
J Kzhyshkowska, J Shen, I Larionova - Cellular & Molecular …, 2024 - nature.com
Аbstract With increasing incidence and geography, cancer is one of the leading causes of
death, reduced quality of life and disability worldwide. Principal progress in the development …
death, reduced quality of life and disability worldwide. Principal progress in the development …
Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
X Liu, B Luo, X Wu, Z Tang - Biochimica et Biophysica Acta (BBA)-Reviews …, 2023 - Elsevier
Breast cancer is one of the most common malignant tumors in women worldwide, and thus, it
is important to enhance its treatment efficacy [1]. Copper has emerged as a critical trace …
is important to enhance its treatment efficacy [1]. Copper has emerged as a critical trace …
Tumor associated macrophages in breast cancer progression: implications and clinical relevance
M Stavrou, A Constantinidou - Frontiers in Immunology, 2024 - frontiersin.org
Macrophages represent an immune cell population characterized by high plasticity and a
range of properties and functions. Their activation status and specific phenotype are highly …
range of properties and functions. Their activation status and specific phenotype are highly …
Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies
Q Li, G He, Y Yu, X Li, X Peng, L Yang - Stem Cell Research & Therapy, 2024 - Springer
Cancer stem cells (CSCs) represent a small yet pivotal subset of tumor cells endowed with
self-renewal capabilities. These cells are intricately linked to tumor progression and are …
self-renewal capabilities. These cells are intricately linked to tumor progression and are …
Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment
X Li, T Chen, X Li, H Zhang, Y Li, S Zhang… - … Hematology & Oncology, 2024 - Springer
Chimeric antigen receptor (CAR) T cell therapy, which targets tumors with high specificity
through the recognition of particular antigens, has emerged as one of the most rapidly …
through the recognition of particular antigens, has emerged as one of the most rapidly …